SMARCA1
Basic information
Region (hg38): X:129446501-129523500
Previous symbols: [ "SNF2L1", "SNF2L" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (Limited), mode of inheritance: Unknown
- X-linked intellectual disability (Limited), mode of inheritance: XL
- neurodevelopmental disorder (Definitive), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (65 variants)
- not_provided (57 variants)
- Neurodevelopmental_disorder (25 variants)
- SMARCA1-related_disorder (3 variants)
- Non-syndromic_X-linked_intellectual_disability (2 variants)
- X-linked_intellectual_disability (1 variants)
- Inborn_genetic_diseases (1 variants)
- Abnormal_brain_morphology (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMARCA1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001282874.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 105 | 111 | ||||
nonsense | 14 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 2 | 12 | 114 | 9 | 4 |
Highest pathogenic variant AF is 9.23979e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SMARCA1 | protein_coding | protein_coding | ENST00000371122 | 24 | 76998 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000161 | 124182 | 0 | 3 | 124185 | 0.0000121 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.44 | 250 | 385 | 0.650 | 0.0000297 | 6949 |
Missense in Polyphen | 59 | 147.19 | 0.40084 | 2574 | ||
Synonymous | 0.785 | 115 | 126 | 0.911 | 0.00000891 | 1915 |
Loss of Function | 6.01 | 2 | 46.0 | 0.0434 | 0.00000405 | 765 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000392 | 0.0000265 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Energy-transducing component of NURF (nucleosome- remodeling factor) and CERF (CECR2-containing-remodeling factor) complexes. Both complexes facilitate the perturbation of chromatin structure in an ATP-dependent manner. Potentiates neurite outgrowth. May be involved in brain development by regulating En-1 and En-2 expression. May be involved in the development of luteal cells. {ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:15310751, ECO:0000269|PubMed:15640247, ECO:0000269|PubMed:16740656}.;
- Pathway
- Nuclear Receptors Meta-Pathway
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.0448
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.88
Haploinsufficiency Scores
- pHI
- 0.992
- hipred
- Y
- hipred_score
- 0.859
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.947
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Smarca1
- Phenotype
- growth/size/body region phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype;
Zebrafish Information Network
- Gene name
- smarca1
- Affected structure
- primitive erythrocyte differentiation
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- DNA strand renaturation;chromatin remodeling;brain development;neuron differentiation;ATP-dependent chromatin remodeling;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;nucleoplasm;NURF complex;intracellular membrane-bounded organelle;CERF complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;helicase activity;protein binding;ATP binding;DNA-dependent ATPase activity;transcription factor binding;nucleosome binding;annealing helicase activity;nucleosome-dependent ATPase activity